Long-term outcome of centrally located hepatocellular carcinoma treated by radical resection combined with adjuvant radiotherapy
10.3760/cma.j.cn113855-20221025-00649
- VernacularTitle:中央型肝细胞癌手术联合辅助放疗对患者长期预后的影响
- Author:
Changcheng TAO
1
;
Weiqi RONG
;
Fan WU
;
Liming WANG
;
Jianxiong WU
Author Information
1. 国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院肝胆外科，北京 100021
- Keywords:
Carcinoma ,hepatocellular;
Surgical procedures,operative;
Adjuvant radiotherapy;
Long-term outcome
- From:
Chinese Journal of General Surgery
2023;38(3):161-166
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the long-term outcome of centrally located hepatocellular carcinoma treated by radical resection and adjuvant radiotherapy(RT).Methods:A retrospective study was used to collect and analyze the clinical and pathological data of 193 patients with centrally located HCC who underwent surgery from Jun 2015 to Jun 2020. According to whether RT was used, these patients were allocated into liver resection (LR) combined RT (88 cases) and LR alone group (105 cases).Results:The 1-, 3-, and 5-year OS rates were 98%, 85%, and 74% for patients in the LR+RT group, and 79%, 66%, and 59% for patients in the LR group, respectively. The 1-, 3-, 5-year RFS rates were 76%, 55% and 44% for patients in the LR+RT group, and 51%, 40%, and 37% for patients in the LR group, respectively. OS and RFS was significantly different in LR+RT group compared with that in LR group (χ 2=5.825, P=0.016;χ 2=5.230, P=0.022, respectively). Cox analysis showed that RT was the independent prognostic factor for centrally located HCC in OS and RFS ( P=0.009, P=0.017, respectively). Subgroup analysis suggested that RT could reduce early recurrence ( HR=0.41,95% CI:0.21-0.80, P=0.002). Conclusion:Liver resection combined with adjuvant radiotherapy for centrally located HCC is safe and effective.
